You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

β-hydroxybutyrate

Showing 1 - 25 of 1,158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aging, Metabolism Disorder, Ketonemia Trial in Aarhus (D-ß-hydroxybutyrate/D 1,3 butanediol monoester)

Recruiting
  • Aging
  • +3 more
  • D-β-hydroxybutyrate/D 1,3 butanediol monoester
  • Aarhus, Aarhus N, Denmark
    Steno Diabetes Center Aarhus
Feb 8, 2023

Colorectal Cancer Trial in Philadelphia (R-1,3-Butanediol)

Recruiting
  • Colorectal Cancer
  • R-1,3-Butanediol
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 26, 2022

Aging Trial in Bath (Ketone drink, Placebo)

Recruiting
  • Aging
  • Ketone drink
  • Placebo
  • Bath, Somerset, United Kingdom
    University of Bath
Sep 28, 2023

Ketosis, Blood Glucose Trial in Kelowna ((R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester, Beta-hydroxybutyric acid,

Recruiting
  • Ketosis
  • Blood Glucose
  • (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester
  • +2 more
  • Kelowna, British Columbia, Canada
    University of British Columbia Okanagan
Apr 22, 2022

Hypertension, Essential, ß-hydroxybutyrate Trial (dietary restriction (salt restriction))

Unknown status
  • Hypertension, Essential
  • β-hydroxybutyrate
  • dietary restriction (salt restriction)
  • (no location specified)
Apr 1, 2020

PreDiabetes Trial in Auckland (HVMN Ketone, Placebo)

Completed
  • PreDiabetes
  • HVMN Ketone
  • Placebo
  • Auckland, New Zealand
    University of Auckland; Auckland City Hospital
Nov 4, 2019

Cardiogenic Shock Trial in Aarhus (KetoneAid Ketone Ester, Maltodextrin)

Completed
  • Cardiogenic Shock
  • KetoneAid Ketone Ester
  • Maltodextrin
  • Aarhus, Midtjylland, Denmark
    Aarhus University Hospital
May 18, 2022

Healthy Trial in San Diego ((R)-1,3-butanediol)

Not yet recruiting
  • Healthy
  • (R)-1,3-butanediol
  • San Diego, California
    Moniker Commons
May 17, 2022

Obesity Trial (LaKe Ester, Placebo)

Not yet recruiting
  • Obesity
  • LaKe Ester
  • Placebo
  • (no location specified)
Jun 14, 2023

Alzheimer Trial in Miami (AC-OLE-01-VA)

Recruiting
  • Alzheimer Disease
  • Miami, Florida
    Quotient Sciences Miami
Jul 18, 2022

Cardiovascular Risk Factor Trial in Blacksburg (Ketone drink, Placebo drink)

Recruiting
  • Cardiovascular Risk Factor
  • Ketone drink
  • Placebo drink
  • Blacksburg, Virginia
    Virginia Polytechnic and State University
Aug 15, 2022

Insulin Resistance Trial in Christchurch (TLC-3595 Dose 1, TLC-3595 Dose 2, Placebo)

Not yet recruiting
  • Insulin Resistance
  • TLC-3595 Dose 1
  • +2 more
  • Christchurch, New Zealand
    New Zealand Clinical Research
Dec 16, 2022

Cerebrovascular Function, Cognition Trial in Hamilton (Low Dose ß-OHB, High Dose ß-OHB, Placebo)

Not yet recruiting
  • Cerebrovascular Function
  • Cognition
  • Low Dose β-OHB
  • +2 more
  • Hamilton, Ontario, Canada
    McMaster University
Sep 8, 2023

Type 1 Diabetes Trial in New Haven (Very Low Carbohydrate Diet)

Completed
  • Type 1 Diabetes
  • Very Low Carbohydrate Diet
  • New Haven, Connecticut
    Yale-New Haven Hospital
Oct 31, 2022

Type 2 Diabetes, Heart Failure, Reduced Ejection Fraction Trial in San Antonio (Ketone Monoester (KE))

Recruiting
  • Type 2 Diabetes
  • Heart Failure, Reduced Ejection Fraction
  • Ketone Monoester (KE)
  • San Antonio, Texas
    University of Texas Health Science Center at San Antonio
Oct 26, 2023

BHB Transport, Alcohol Use Disorder Trial (Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans)

Not yet recruiting
  • BHB Transport
  • Alcohol Use Disorder
  • Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans
  • (no location specified)
Jun 30, 2023

Cerebrovascular Function, Cognition Trial (Placebo, ß-OHB)

Not yet recruiting
  • Cerebrovascular Function
  • Cognition
  • Placebo
  • β-OHB
  • (no location specified)
Aug 7, 2023

Type 1 Diabetes Trial in New Haven (Insulin Degludec, Insulin Glargine)

Completed
  • Type 1 Diabetes Mellitus
  • Insulin Degludec
  • Insulin Glargine
  • New Haven, Connecticut
    Yale University
Nov 4, 2021

Alzheimer Trial in Adelaide (AC-1202, AC-OLE-01, AC-OLE-02)

Recruiting
  • Alzheimer Disease
  • Adelaide, South Australia, Australia
    CMAX
Sep 30, 2021

Heart Failure, Reduced Ejection Fraction Trial in Paris (Dapagliflozin)

Recruiting
  • Heart Failure
  • Reduced Ejection Fraction
  • Paris, France
    Pitié-Salpêtrière Hospital
Dec 7, 2022

Salt; Excess, Hypertension Trial in Auburn (No Salt, No ß-OHB, High Salt, No ß-OHB, High Salt, High ß-OHB)

Not yet recruiting
  • Salt; Excess
  • Hypertension
  • No Salt, No β-OHB
  • +2 more
  • Auburn, Alabama
    Auburn University
Jan 31, 2023

Healthy Participants Trial in New Haven (Glucagon)

Active, not recruiting
  • Healthy Participants
  • New Haven, Connecticut
    Yale Hospital reserach Unit / YCCI
Jan 17, 2022

Fatty Liver Trial in Helsinki (Low Carbohydrate Diet)

Recruiting
  • Fatty Liver
  • Low Carbohydrate Diet
  • Helsinki, Uusimaa, Finland
    Biomedicum 2U
Aug 23, 2021

Kidney Failure, Hemodialysis, Diabetes, Type 2 Trial (Dapagliflozin 10 MG, Placebo)

Not yet recruiting
  • Kidney Failure
  • +4 more
  • Dapagliflozin 10 MG
  • Placebo
  • (no location specified)
Aug 23, 2022

Polycystic Kidney, Autosomal Dominant Trial in Aurora (Dietary)

Active, not recruiting
  • Polycystic Kidney, Autosomal Dominant
  • Dietary
  • Aurora, Colorado
    University of Colorado - Anschutz Medical Campus
May 16, 2022